title: Oxidized, Regenerated Cellulose Adhesion Barrier Plus Intrauterine Device Prevents Recurrence After Adhesiolysis for Moderate to Severe Intrauterine Adhesions.
abstract: To compare the efficacy of an oxidized, regenerated cellulose adhesion barrier (Interceed; Ethicon, Somerville, NJ) combined with an intrauterine device (IUD) versus an IUD alone for preventing adhesion recurrence following hysteroscopic adhesiolysis for moderate to severe intrauterine adhesions (IUAs).
  
  
  
  Retrospective case series (Canadian Task Force classification III).
  
  
  
  Tertiary care teaching hospital.
  
  
  
  Patients undergoing treatment for moderate to severe IUAs. The severity of IUA was determined based on the American Fertility Society scoring system (mild, moderate, or severe).
  
  
  
  All cases of hysteroscopic adhesiolysis were reviewed.
  
  
  
  Seventy-six women with moderate to severe IUAs treated between March 2009 and August 2015 were included. After hysteroscopic adhesiolysis, 35 patients were treated with an IUD alone (group 1), and 41 patients were treated with Interceed plus an IUD (group 2). A second hysteroscopy was performed in all cases three months after the initial hysteroscopy and both groups achieved significant reduction in adhesion scores and grade, especially in group 2 (scores, p < .001; grade, p = .039). Compared with group 1, menstruation dysfunction, pregnancy rate, and live birth rate in group 2 improved with no statistical difference (menstruation improvement, p = .764; pregnancy rate, p = .310; live birth rate, p = .068). However, an adhesion-free uterine cavity was regained significantly owing to the fewer operations in group 2 compared with group 1 (median, 3 vs 4; p = .001). The interval from initial hysteroscopy to conception was significantly shorter in group 2 (median, 12 months vs 51 months; p < .001).
  
  
  
  For moderate to severe IUAs, Interceed combined with an IUD may be an alternative approach for reducing adhesion recurrence after hysteroscopic adhesiolysis.
authors.affiliation: Department of Obstetrics and Gynecology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
authors.forename: Huihua
authors.initials: H
authors.lastname: Cai
authors.affiliation: Department of Obstetrics and Gynecology, General Hospital of PLA Guangzhou Military Area, Guangzhou, Guangdong, China.
authors.forename: Lin
authors.initials: L
authors.lastname: Qiao
authors.affiliation: Department of Obstetrics and Gynecology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
authors.forename: KaiJing
authors.initials: K
authors.lastname: Song
authors.affiliation: Department of Obstetrics and Gynecology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China. Electronic address: heyuanli310@163.com.
authors.forename: Yuanli
authors.initials: Y
authors.lastname: He
mesh_terms: D000328:Adult; D002483:Cellulose, Oxidized / Q000627:therapeutic use*; D005260:Female; D006490:Hemostatics / Q000627:therapeutic use*; D006801:Humans; D015907:Hysteroscopy; D007434:Intrauterine Devices; D012189:Retrospective Studies; D012720:Severity of Illness Index; D000267:Tissue Adhesions / Q000517:prevention & control*
chemical_list: D002483:Cellulose, Oxidized; D006490:Hemostatics; C060002:INTERCEED
keywords: Adhesion recurrence; Adhesion reduction; Asherman's syndrome; Hysteroscopy; Menstrual dysfunction; Pregnancy rate; Uterine synechiae